questionText: To ask the Secretary of State for Health and Social Care, whether he plans to (a) utilise the complex patient access scheme to make Ruxolitinib available on the NHS and (b) consider other options for vitiligo patients to receive that medication.
answerText: It is for the marketing authorisation holder to propose a complex patient access scheme for a medicine being evaluated by the National Institute for Health and Care Excellence (NICE), which would then be considered by the NICE and NHS England through the ...
heading: Ruxolitinib